MTC 03 II-07Conclusion: which test for which circumstances: countries, target users, population, sites

10. HPV testing
P. Gravitt 1.
1Dept of Global Health (United States)

Background / Objectives

does not apply


Methods

does not apply


Results

does not apply


Conclusion

The revolution in molecular diagnostics has led to the development of a marvelous array of options for the prevention and management of HPV-associated diseases.  The evidence base for any individual test or strategy varies, but is generally quite strong, moving the conversation increasingly away from strict ranking of test performance to discussions of which test is best able to meet the needs and resources of the situation.  This talk will discuss the opportunities these technologies provide to locally adapted and appropriate HPV-associated disease prevention.The revolution in molecular diagnostics has led to the development of a marvelous array of options for the prevention and management of HPV-associated diseases.  The evidence base for any individual test or strategy varies, but is generally quite strong, moving the conversation increasingly away from strict ranking of test performance to discussions of which test is best able to meet the needs and resources of the situation.  This talk will discuss the opportunities these technologies provide to locally adapted and appropriate HPV-associated disease prevention.


References

does not apply